Report - MEmbranous Nephropathy Trial Of Rituximab (MENTOR) NCT ...€¦ · surrogate marker and principal endpoint in clinical trials in proteinuric renal disease where GFR-based declines

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form